Ruboxistaurin for the treatment of diabetic peripheral neuropathy: a systematic review of randomized clinical trials.
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. Protein kinase C (PKC) inhibitor's has been thought to be a potential disease modifying drug's in DPN as it slows or reverse neuropathy's progression. To asses..... Read More